Novartis could lose years of patent protection in the US for its blockbuster multiple sclerosis therapy Gilenya, after a federal appeals verdict went against the company. The litigation revolves ...

Discover the leading database management systems for enterprises in 2026. Explore key features, pricing, and implementation tips for selecting the best DBMS software to harness your data effectively.

Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an experienced financial ...

Award-winning senior researcher/writer with 25 years' experience writing about wellbeing, covering everything from indigestion remedies to insect repellents. Heartburn doesn’t just strike after ...